Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

TMCI - TREACE MEDICAL CONCEPTS, INC.

IEX Last Trade
7.07
-0.010   -0.141%

Share volume: 6,525
Last Updated: Thu 26 Dec 2024 08:30:17 PM CET
Surgical and Medical Instrument Manufacturing : 1.09%

PREVIOUS CLOSE
CHG
CHG%
$7.08
-0.01
-0.14%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
16%
Profitability 8%
Dept financing 21%
Liquidity 73%
Performance 9%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0.14%
1 Month
-15.82%
3 Months
20.17%
6 Months
10.81%
1 Year
-45.07%
2 Year
-70.87%
Key data
Stock price
$7.07
P/E Ratio 
-6.03
DAY RANGE
$6.86 - $7.10
EPS 
-$1.03
52 WEEK RANGE
$4.49 - $15.98
52 WEEK CHANGE
-$45.89
MARKET CAP 
383.714 M
YIELD 
N/A
SHARES OUTSTANDING 
62.190 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
1.81
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$238,975
AVERAGE 30 VOLUME 
$287,490
Company detail
CEO: John T. Treace
Region: US
Website: treace.com
Employees: 250
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement.

Recent news